JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Cellectar Biosciences Inc

Closed

2.97 7.22

Overview

Share price change

24h

Current

Min

2.9699999999999998

Max

3.06

Key metrics

By Trading Economics

Employees

11

Market Stats

By TradingEconomics

Market Cap

15M

Previous open

-4.25

Previous close

2.97

Cellectar Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 Feb 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 Feb 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 Feb 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 Feb 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 Feb 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 Feb 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 Feb 2026, 22:55 UTC

Earnings

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 Feb 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 Feb 2026, 22:55 UTC

Earnings

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 Feb 2026, 22:55 UTC

Earnings

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 Feb 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 Feb 2026, 22:55 UTC

Earnings

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 Feb 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 Feb 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 Feb 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 Feb 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 Feb 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 Feb 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 Feb 2026, 02:46 UTC

Acquisitions, Mergers, Takeovers

Big Money, High Anxiety -- Barrons.com

6 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 Feb 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 Feb 2026, 21:40 UTC

Acquisitions, Mergers, Takeovers

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 Feb 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 Feb 2026, 21:17 UTC

Earnings

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 Feb 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Feb 2026, 21:14 UTC

Acquisitions, Mergers, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 Feb 2026, 21:13 UTC

Earnings

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 Feb 2026, 21:13 UTC

Earnings

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 Feb 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 Feb 2026, 20:34 UTC

Earnings

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Peer Comparison

Price change

Cellectar Biosciences Inc Forecast

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Financials

$

help-icon Live chat